Eureka Therapeutics, Inc.

Industry
Biological Products, (No Disgnostic Substances) (Office Of Life Sciences)
Business address
5858 Horton St Ste 170, Emeryville, CA, 94608
Top holdings (ownership)
ESLA
State of incorporation
DE
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Eureka Therapeutics, Inc. has filed 11 SEC EDGAR filings since 08 Jan 2007

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
SC 13D Open Document Open Filing SCHEDULE 13D 30 Oct 2023
3 Open Document Open Filing 10 Oct 2023 29 Sep 2023 001-40608
D Open Document Open Filing 17 May 2023 021-481903
D Open Document Open Filing 24 Jan 2020 021-358835
D Open Document Open Filing 18 Jun 2018 021-314816
D/A Open Document Open Filing 30 May 2017 021-276040
D Open Document Open Filing 12 Dec 2016 021-276040
D Open Document Open Filing 22 Sep 2014 021-225088